i
n
f
l
a
r
x
Loading
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
Event - Presentation
Home
Investors
Events
Event - Presentation
INF904 Topline Phase I SAD Results
InflaRx News Conference Call
Date:
Monday, September 11th
Time
8:30 am EDT (14:30 CEST)
Webcast
Presentation
Back